Suchergebnisse - "Ependymoma"

PubPharm (2.798)

1

Ependymomas of the spinal region in adults : Clinical and pathological features and MYCN expression levels in spinal ependymomas and myxopapillary ependymomas

enthalten in: Annals of diagnostic pathology | 2024

von Topel, G. | Dirilenoğlu, F. | Sevin, �. | +1

2

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms : A First-in-human Phase I Single-agent Dose-escalation, Food Effect and Dose Expansion Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

enthalten in: ClinicalTrials.gov | 2024

3

MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas

enthalten in: Human cell | 2024

von Mohan, D. | Nambirajan, A. | Malik, R. | +8

4

Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors : An Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

enthalten in: ClinicalTrials.gov | 2024

5

Supratentorial extra-ventricular ependymoma as a mass lesion in a child : report and literature review

enthalten in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery | 2024

von Kumarasamy, S. | Satyarthee, G.

6

Is proton beam therapy always better than photon irradiation? Lessons from two cases

enthalten in: Journal of medical radiation sciences | 2024

von Li, M. | Yeo, A. | Gunewardena, R. | +6

7

A case of myxopapillary ependymoma with predominant giant cell morphology : A rare entity with comprehensive genomic profiling and review of literature

enthalten in: Neuropathology : official journal of the Japanese Society of Neuropathology | 2024

von Morales-Vargas, B. | Saad, H. | Refai, D. | +4

8

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma : A Safety and Preliminary Efficacy Trial of Pembrolizumab (MK-3475) in Children With Recurrent, Progressive or Refractory Diffuse Intrinsic Pontine Glioma (DIPG), Non-Brainstem High-Grade Gliomas (NB-HGG), Ependymoma, Medulloblastoma or Hypermutated Brain Tumors

enthalten in: ClinicalTrials.gov | 2024

9

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol

enthalten in: ClinicalTrials.gov | 2024

10

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Tipifarnib in Patients With Tumors Harboring HRAS Genomic Alterations

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[280]